Inventor
NAGPAL SUNIL
US31 patents
⚠️ This page may combine multiple inventors who share the name “NAGPAL SUNIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN SALES INC
10 patentsUS5958954ASep 28, 1999
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN SALES INC176 citations99
US5877207AMar 2, 1999
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN SALES INC245 citations99
US6218128B1Apr 17, 2001
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
ALLERGAN SALES INC82 citations96
US6090810AJul 18, 2000
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN SALES INC59 citations96
US6008204ADec 28, 1999
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN SALES INC55 citations96
US5952345ASep 14, 1999
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN SALES INC83 citations96
US6034110AMar 7, 2000
Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid and a PPARγ ligand
ALLERGAN SALES INC18 citations93
US6025388AFeb 15, 2000
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
ALLERGAN SALES INC18 citations91
US6294657B1Sep 25, 2001
Retinoid induced gene
ALLERGAN SALES INC8 citations72
US6369100B1Apr 9, 2002
Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
ALLERGAN SALES INC1 citations50
ALLERGAN INC
10 patentsUS5776699AJul 7, 1998
Method of identifying negative hormone and/or antagonist activities
ALLERGAN INC223 citations99
US6942980B1Sep 13, 2005
Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
ALLERGAN INC55 citations96
US6521624B1Feb 18, 2003
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN INC39 citations96
US6228848B1May 8, 2001
Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
ALLERGAN INC65 citations96
US6075032AJun 13, 2000
Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
ALLERGAN INC46 citations96
US6071924AJun 6, 2000
Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
ALLERGAN INC17 citations92
US6372753B1Apr 16, 2002
Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
ALLERGAN INC12 citations82
US6469028B1Oct 22, 2002
Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
ALLERGAN INC8 citations74
US5650279AJul 22, 1997
Gene sequence induced in skin by retinoids
ALLERGAN INC10 citations74
US5776687AJul 7, 1998
Retinoid induced gene
ALLERGAN INC12 citations72
LILLY CO ELI
8 patentsUS7595345B2Sep 29, 2009
Vitamin D receptor modulators
LILLY CO ELI16 citations83
US7582775B2Sep 1, 2009
Vitamin D receptor modulators
LILLY CO ELI4 citations60
US7772425B2Aug 10, 2010
Vitamin D receptor modulators
LILLY CO ELI0 citations51
US7750184B2Jul 6, 2010
Vitamin D receptor modulators
LILLY CO ELI1 citations50
US7897789B2Mar 1, 2011
Vitamin D receptor modulators
LILLY CO ELI0 citations49
US7601850B2Oct 13, 2009
Phenyl-thiophene type vitamin D receptor modulators
LILLY CO ELI1 citations48
US7468449B2Dec 23, 2008
Phenyl-furan compounds as vitamin D receptor modulators
LILLY CO ELI0 citations41
US7579488B2Aug 25, 2009
Vitamin D receptor modulators
LILLY CO ELI0 citations40